Canada markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
279.910.00 (0.00%)
At close: 03:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.85B
Enterprise Value 7.64B
Trailing P/E N/A
Forward P/E 25.13
PEG Ratio (5 yr expected) 1.06
Price/Sales (ttm)3.06
Price/Book (mrq)0.91
Enterprise Value/Revenue 2.86
Enterprise Value/EBITDA -11.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-40.18%
S&P500 52-Week Change 323.57%
52 Week High 3467.95
52 Week Low 3271.00
50-Day Moving Average 3323.53
200-Day Moving Average 3335.80

Share Statistics

Avg Vol (3 month) 3280
Avg Vol (10 day) 350
Shares Outstanding 55.1M
Implied Shares Outstanding 628.97M
Float 819.96M
% Held by Insiders 197.55%
% Held by Institutions 10.07%
Shares Short (Apr 15, 2024) 411
Short Ratio (Apr 15, 2024) 40.58
Short % of Float (Apr 15, 2024) 40.01%
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Mar 15, 2024) 412

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 08, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -23.86%
Operating Margin (ttm)14.24%

Management Effectiveness

Return on Assets (ttm)1.77%
Return on Equity (ttm)-6.94%

Income Statement

Revenue (ttm)2.67B
Revenue Per Share (ttm)91.45
Quarterly Revenue Growth (yoy)-6.70%
Gross Profit (ttm)N/A
EBITDA 511.6M
Net Income Avi to Common (ttm)-637.32M
Diluted EPS (ttm)-21.83
Quarterly Earnings Growth (yoy)-57.80%

Balance Sheet

Total Cash (mrq)1.61B
Total Cash Per Share (mrq)56.35
Total Debt (mrq)1.41B
Total Debt/Equity (mrq)16.08%
Current Ratio (mrq)5.83
Book Value Per Share (mrq)306.51

Cash Flow Statement

Operating Cash Flow (ttm)374.9M
Levered Free Cash Flow (ttm)170.82M